Individualized Short Antibiotic Course Is Cost Effective For VAP In Nepal, Thailand, And Singapore, Research Finds

Healio (2/24) reports that “in Nepal, Thailand and Singapore, an individualized short antibiotic course vs. usual care was estimated to be cost effective for the treatment of ventilator-associated pneumonia.” The researchers said, “We found that an individualized short-course antibiotics strategy in patients with VAP is likely to be cost-effective in high-income, middle-income and low-income settings, although with evident uncertainty.” The findings also concluded that “Thailand had the highest likelihood of the short antibiotic course being cost-effective based on willingness-to-pay thresholds.” The findings were published in The Lancet Global Health.